from Reuters: Health News https://ift.tt/2rNxuFQ
Loxo Oncology's targeted RET drug shows promise in early trial
CHICAGO (Reuters) - An experimental Loxo Oncology Inc drug that targets cancers with mistakes in the RET gene led to tumor shrinkage in nearly 70 percent of patients regardless of where their cancer originated, according to preliminary data from a small study released on Wednesday.
from Reuters: Health News https://ift.tt/2rNxuFQ
from Reuters: Health News https://ift.tt/2rNxuFQ
Subscribe to:
Post Comments (Atom)
-
Sometimes the best paleo snacks are frozen ones. Wether it’s because of hot weather, after a workout or just because you want to feel light ...
-
Let’s be honest: we put our hair through a lot — from heat styling to dye jobs and loading it with product. So, it’s about time our strands...
-
Paleo Grubs Paleo Grubs - She told me that she adds molasses to give it that specific taste. She brought the bottle out for me to dip my ...
No comments:
Post a Comment